Explore more publications!
Health Times of Rhode Island
Got News to Share?

Health Times of Rhode Island: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Rhode Island.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 23, 2026

Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
January 23, 2026

Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity

Indeterminate GlobeNewswire
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
January 23, 2026

AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026

Indeterminate GlobeNewswire
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
January 23, 2026

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire
NextCure Provides Business Update 
January 23, 2026

NextCure Provides Business Update 

Indeterminate GlobeNewswire
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
January 23, 2026

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

Indeterminate GlobeNewswire
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
January 23, 2026

FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

Indeterminate GlobeNewswire
BlissBot Announces the Global Launch of StarHealing: A Quantum-Inspired Program in Autism Intervention
January 23, 2026

BlissBot Announces the Global Launch of StarHealing: A Quantum-Inspired Program in Autism Intervention

Indeterminate GlobeNewswire
ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
January 23, 2026

ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer

Indeterminate GlobeNewswire
Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
January 23, 2026

Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis

Indeterminate GlobeNewswire
Communiqué de presse : L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique
January 23, 2026

Communiqué de presse : L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique

Indeterminate GlobeNewswire
NASP Applauds House Passage of Landmark Bill to Protect Patient Access to Specialty Pharmacies and Support Specialty Pharmacy Businesses
January 23, 2026

NASP Applauds House Passage of Landmark Bill to Protect Patient Access to Specialty Pharmacies and Support Specialty Pharmacy Businesses

Indeterminate GlobeNewswire
Cheapest Compounded Semaglutide Without Insurance in 2026: What "Low-Cost" GLP-1 Pricing Often Excludes — SynergyRx Consumer Analysis
January 23, 2026

Cheapest Compounded Semaglutide Without Insurance in 2026: What "Low-Cost" GLP-1 Pricing Often Excludes — SynergyRx Consumer Analysis

Indeterminate GlobeNewswire
Relevance releases 2026 Healthcare SEO & GEO Playbook to help healthcare brands win in Google and AI answer engines
January 23, 2026

Relevance releases 2026 Healthcare SEO & GEO Playbook to help healthcare brands win in Google and AI answer engines

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions